Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
Damora Therapeutics | Buy | $45 | |
Corcept Therapeutics | Buy | $165 | |
Visa | Buy | $450 | |
Centrus Energy | Buy | $280 | |
VSE | Buy | ― | |
Cognizant | Buy | $70 | |
California Resources Corp | Buy | $91 | |
Navan, Inc. Class A | Buy | $33 | |
Take-Two | Buy | $280 |
Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
Damora Therapeutics | Buy | $45 | |
Corcept Therapeutics | Buy | $165 | |
Visa | Buy | $450 | |
Centrus Energy | Buy | $280 | |
VSE | Buy | ― | |
Cognizant | Buy | $70 | |
California Resources Corp | Buy | $91 | |
Navan, Inc. Class A | Buy | $33 | |
Take-Two | Buy | $280 |